Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00079391
What this trial is testing

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

Who this might be right for
Hematologic MalignanciesBone Marrow Transplant Rejection
National Heart, Lung, and Blood Institute (NHLBI) 50
Testing effectiveness (Phase 2)Study completedNCT00558675
What this trial is testing

A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy

Who this might be right for
Hematological MalignancyLeukemiaLymphoma+1 more
Mirror Biologics, Inc. 6
Early research (Phase 1)UnknownNCT05549557
What this trial is testing

IMM40H Phase I Dose Escalation and Expansion

Who this might be right for
Tumor
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 16
Testing effectiveness (Phase 2)Ended earlyNCT03875495
What this trial is testing

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Who this might be right for
Multiple Myeloma
Genenta Science 9
Testing effectiveness (Phase 2)Study completedNCT00378534
What this trial is testing

Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaChronic Lymphocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Ended earlyNCT03605212
What this trial is testing

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults

Who this might be right for
Tumor Lysis Syndrome
Menarini Group 30
Testing effectiveness (Phase 2)WithdrawnNCT04016116
What this trial is testing

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

Who this might be right for
CancerHematological Malignancy
NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT04333914
What this trial is testing

Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection

Who this might be right for
SARS-CoV-2 (COVID-19) InfectionAdvanced or Metastatic Hematological or Solid Tumor
Centre Leon Berard 19
Testing effectiveness (Phase 2)Ended earlyNCT02074436
What this trial is testing

PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

Who this might be right for
Hematological MalignanciesThrombocytopenia
Emory University 29
Post-approval studies (Phase 4)Study completedNCT02564094
What this trial is testing

Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies

Who this might be right for
Anemia
Hoffmann-La Roche 54
Testing effectiveness (Phase 2)UnknownNCT00866762
What this trial is testing

The Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Copenhagen University Hospital at Herlev 60
Testing effectiveness (Phase 2)Looking for participantsNCT05658640
What this trial is testing

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Not applicableUnknownNCT05099237
What this trial is testing

Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester

Who this might be right for
Colorectal CancerLung CancerHematological Cancer+1 more
Manchester University NHS Foundation Trust 80
Not applicableUnknownNCT05486273
What this trial is testing

Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells

Who this might be right for
Hematological Cancer
Institut Paoli-Calmettes 108
Testing effectiveness (Phase 2)Study completedNCT03118986
What this trial is testing

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Vomiting in Infants and/or ChildrenNauseaHematopoietic System--Cancer+1 more
The Hospital for Sick Children 161
Early research (Phase 1)Looking for participantsNCT05887167
What this trial is testing

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Who this might be right for
Hematologic MalignancyLarge B-cell LymphomaAcute Lymphoblastic Leukemia+3 more
Joshua Sasine, MD, PhD 20
Large-scale testing (Phase 3)UnknownNCT06238336
What this trial is testing

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Who this might be right for
Hematological Malignancy
Shanxi Bethune Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT02465528
What this trial is testing

Ceritinib Rare Indications Study in ALK+ Tumors

Who this might be right for
Tumors With Aberrations in ALKAnaplastic Large Cell LymphomaInflammatory Myofibroblastic Tumor+1 more
Novartis Pharmaceuticals 22
Next Page
26